{"id":"W2036506340","doi":"10.1056/nejmoa076016","title":"Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1296,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Bayer HealthCare; Sanofi","keywords":"Medicine; Rivaroxaban; Arthroplasty; Total knee arthroplasty; Enoxaparin sodium; Surgery; Thrombosis; Warfarin; Low molecular weight heparin; Internal medicine; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02755619217994649,"score_gpt":0.2749491392872486,"score_spread":0.2473929471073021,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}